Management of atrial fibrillation in chronic kidney disease: Double trouble

American Heart Journal

Volumn 166, Issue 2, 2013, Pages 230-239

  Nimmo, Camus ^a   Wright, Matthew ^a   Goldsmith, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DABIGATRAN; DIGOXIN; DOFETILIDE; DRONEDARONE; FLECAINIDE; IBUTILIDE; PROPAFENONE; RIVAROXABAN; SOTALOL; TICAGRELOR; WARFARIN; XIMELAGATRAN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD VESSEL CALCIFICATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL ABSORPTION; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY DISEASE; LIVER TOXICITY; NEUROIMAGING; PHASE 3 CLINICAL TRIAL (TOPIC); PLATELET REACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE ACTIVATION; THROMBOSIS;

EID: 84880924477     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.05.010     Document Type: Review

References (64)

1. J. Coresh, E. Selvin, and L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047 (Pubitemid 350074801)
2. J.B. Wetmore, J.D. Mahnken, and S.K. Rigler The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients Kidney Int 81 5 2012 469 476
3. E.Z. Soliman, R.J. Prineas, and A.S. Go Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC) Am Heart J 159 6 2010 1102 1107
4. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2010 2369 2429
5. Y. Iguchi, K. Kimura, and K. Kobayashi Relation of atrial fibrillation to glomerular filtration rate Am J Cardiol 102 8 2008 1056 1059
6. R. Hajhosseiny, K. Khavandi, and D. Goldsmith Cardiovascular Disease in chronic kidney disease: untying the Gordian knot (in press) Int J Clin Pract 2012
7. G. Marenzi, A. Cabiati, and E. Assanelli Chronic kidney disease in acute coronary syndromes World J Nephrol 1 5 2012 134 145
8. D.N. Reddan Therapy for cardiovascular disease in patients with chronic kidney disease: appropriate caution or the absence of data Am Heart J 144 2 2002 206 207 (Pubitemid 34879639)
9. Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators Stroke 21 4 1990 538 545
10. L.M. Miller, M.M. Sood, and A.R. Sood Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients Int Urol Nephrol 42 4 2010 1007 1014
11. H. Reinecke, E. Brand, and R. Mesters Dilemmas in the management of atrial fibrillation in chronic kidney disease J Am Soc Nephrol 20 4 2009 705 711
12. R. Hajhosseiny, K. Khavandi, and D.J. Goldsmith Cardiovascular disease in chronic kidney disease: untying the Gordian knot Int J Clin Pract 67 1 2013 14 31
13. M. Jenkins, and D. Goldsmith Statins and kidney disease: is the study of heart and renal protection at the cutting edge of evidence? Curr Opin Cardiol 27 4 2012 429 440
14. E.P. Heymann, T.I. Kassimatis, and D.J. Goldsmith Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era J Nephrol 2012 460 472
15. E.S. Williams, V.P. Thompson, and K.E. Chiswell Rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III trial Heart Rhythm 2012 Boston, MA, USA
16. M. Schmidt, M. Daccarett, and H. Rittger Renal dysfunction and atrial fibrillation recurrence following cardioversion J Cardiovasc Electrophysiol 22 10 2011 1092 1098
17. N.K. Foundation KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease 2004
18. C.D. Payton, J.G. Fox, and N.F. Pauleau The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance Eur Heart J 8 Suppl. M 1987 15 22 (Pubitemid 18088432)
19. M. Wright, M. Haïssaguerre, and S. Knecht State of the art: catheter ablation of atrial fibrillation J Cardiovasc Electrophysiol 19 6 2008 583 592 (Pubitemid 351843402)
20. Y. Naruse, H. Tada, and Y. Sekiguchi Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up Heart Rhythm 8 3 2011 335 341
21. A. Sairaku, Y. Yoshida, and H. Kamiya Outcomes of ablation of paroxysmal atrial fibrillation in patients on chronic hemodialysis J Cardiovasc Electrophysiol 2012
22. CABANA trial (clinicaltrials.gov). In.
23. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 8 1991 983 988
24. L. Friberg, N. Hammar, and M. Rosenqvist Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation Eur Heart J 31 8 2010 967 975
25. M. Wiesholzer, F. Harm, and G. Tomasec Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation Am J Nephrol 21 1 2001 35 39 (Pubitemid 32238611)
26. E. Vázquez, C. Sánchez-Perales, and F. Borrego Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis Am Heart J 140 6 2000 886 890
27. E. Vázquez, C. Sanchez-Perales, and F. Garcia-Garcia Atrial fibrillation in incident dialysis patients Kidney Int 76 3 2009 324 330
28. R.G. Hart, L.A. Pearce, and R.W. Asinger Warfarin in atrial fibrillation patients with moderate chronic kidney disease Clin J Am Soc Nephrol 6 11 2011 2599 2604
29. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 12 2007 857 867 (Pubitemid 351650486)
30. S. Apostolakis, D.A. Lane, and Y. Guo Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) study J Am Coll Cardiol 60 9 2012 861 867
31. R. Pisters, D.A. Lane, and R. Nieuwlaat A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 5 2010 1093 1100
32. R. Sreedhara, I. Itagaki, and B. Lynn Defective platelet aggregation in uremia is transiently worsened by hemodialysis Am J Kidney Dis 25 4 1995 555 563
33. M.J. Janssen, and J. van der Meulen The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients Neth J Med 48 5 1996 198 207
34. L. Friberg, M. Rosenqvist, and G.Y. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study Eur Heart J 2012
35. K.E. Chan, J.M. Lazarus, and R. Thadhani Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation J Am Soc Nephrol 20 10 2009 2223 2233
36. H.M. Lai, W.S. Aronow, and P. Kalen Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin Int J Nephrol Renovasc Dis 2 2009 33 37
37. J.B. Olesen, G.Y. Lip, and A.L. Kamper Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 7 2012 625 635
38. M. El-Abbadi, and C.M. Giachelli Mechanisms of vascular calcification Adv Chronic Kidney Dis 14 1 2007 54 66 (Pubitemid 46014536)
39. H.M. Spronk, B.A. Soute, and L.J. Schurgers Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall Biochem Biophys Res Commun 289 2 2001 485 490 (Pubitemid 33141080)
40. R. Koos, A.H. Mahnken, and G. Mühlenbruch Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography Am J Cardiol 96 6 2005 747 749 (Pubitemid 41317640)
41. A. Fine, and J. Zacharias Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy Kidney Int 61 6 2002 2210 2217 (Pubitemid 34546039)
42. S.V. Brodsky, A. Satoskar, and J. Chen Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases Am J Kidney Dis 54 6 2009 1121 1126
43. S.V. Brodsky, T. Nadasdy, and B.H. Rovin Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate Kidney Int 80 2 2011 181 189
44. J.W. Eikelboom, S.J. Connolly, and P. Gao Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease J Stroke Cerebrovasc Dis 21 6 2012 429 435
45. D.J. Angiolillo, E. Bernardo, and D. Capodanno Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy J Am Coll Cardiol 55 11 2010 1139 1146
46. G. Montalescot, and J. Silvain Ticagrelor in the renal dysfunction subgroup: subjugated or substantiated? Circulation 122 11 2010 1049 1052
47. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 12 2009 1139 1151
48. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 10 2011 883 891
49. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 11 2011 981 992
50. G. Paré, N. Eriksson, and T. Lehr Genetic determinants of dabigatran plasma levels and their relation to bleeding Circulation 2013
51. R. Alikhan, R. Rayment, and D. Keeling The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran Emerg Med J 2013
52. S.H. Hohnloser, Z. Hijazi, and L. Thomas Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial Eur Heart J 2012
53. A.G. Kocheril Arrhythmia issues in patients with renal disease Semin Nephrol 21 1 2001 57 65 (Pubitemid 32102177)
54. B.N. Singh, S.J. Connolly, and H.J. Crijns Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 10 2007 987 999 (Pubitemid 47367078)
55. P. Varriale, and A. Sedighi Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide? Clin Cardiol 23 4 2000 265 268 (Pubitemid 30183391)
56. L. Køber, P.E. Bloch Thomsen, and M. Møller Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial Lancet 356 9247 2000 2052 2058 (Pubitemid 32009820)
57. S.M. Ting, D. Lee, and D. Maclean Paranoid psychosis and myoclonus: flecainide toxicity in renal failure Cardiology 111 2 2008 83 86
58. S. Genovesi, A. Vincenti, and E. Rossi Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients Am J Kidney Dis 51 2 2008 255 262
59. A.S. Go, M.C. Fang, and N. Udaltsova Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study Circulation 119 10 2009 1363 1369
60. W.C. Winkelmayer, J. Liu, and S. Setoguchi Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation Clin J Am Soc Nephrol 6 11 2011 2662 2668
61. F. Knoll, G. Sturm, and C. Lamina Coumarins and survival in incident dialysis patients Nephrol Dial Transplant 27 1 2012 332 337
62. S.J. Connolly, J. Eikelboom, and C. Joyner Apixaban in patients with atrial fibrillation N Engl J Med 364 9 2011 806 817
63. J. Stangier, K. Rathgen, and H. Stähle Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study Clin Pharmacokinet 49 4 2010 259 268
64. M.R. Wanek, E.T. Horn, and S. Elapavaluru Safe use of hemodialysis for dabigatran removal before cardiac surgery Ann Pharmacother 46 9 2012 e21